Vol 16; Is­sue 09; Septem­ber 2018

BioSpectrum (India) - - BIO MAIL -

At­tend­ing to Alzheimer’s

The lack of fun­da­men­tal knowl­edge about Alzheimer’s is the key rea­son why we have not been suc­cess­ful or close to pre­vent­ing or slow­ing down the dis­ease. But of course world­wide ef­forts are be­ing made to val­i­date ex­ist­ing ther­a­peu­tics and dis­cover newer tar­gets. Hop­ing to find a so­lu­tion soon.

- Dr Aravind Kishore, Mum­bai

Cut­ting edge pros­thet­ics

Al­though good pros­thet­ics and re­place­ments are grad­u­ally be­com­ing avail­able, am­pu­ta­tions are best pre­ventable by pro­vi­sion of health ed­u­ca­tion, early pre­sen­ta­tion and ap­pro­pri­ate man­age­ment of the com­mon in­di­ca­tions.

- Ni­har Param­bil, Ben­galuru

Vac­cine Pro­duc­tion

It is great to know that In­dian com­pa­nies are do­ing well in giv­ing a tough fight to es­tab­lished play­ers and ac­quir­ing global mar­ket share in the vac­cine R&D do­main. It would be best if the In­dian firms col­lab­o­rate with the gov­ern­ment and ex­pand their cov­er­age of vac­cines in In­dia. This will im­prove their mar­ket pen­e­tra­tion.

- Ravi Verma, New Delhi

Ban Ef­fect

With the re­cent call by the Health Min­istry on ban­ning 328 com­bi­na­tion drugs, a big hole has been made in the pocket of many pharma com­pa­nies. But the gov­ern­ment has made a ra­tio­nal de­ci­sion by keep­ing pa­tient safety as the pri­or­ity.

- Leena Paul, Nag­pur

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.